THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE
<p>A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally different mechanisms of action, is presented in patients with chronic heart failure (CHF) on the base of GISSI-HF and SHIFT trails results. It is essential to compaire an effect of these drugs on the...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | http://www.rpcardio.ru/jour/article/view/561 |
| _version_ | 1797766866660229120 |
|---|---|
| author | S. N. Tereshchenko I. V. Zhirov A. G. Kochetov O. V. Uspenskaya |
| author_facet | S. N. Tereshchenko I. V. Zhirov A. G. Kochetov O. V. Uspenskaya |
| author_sort | S. N. Tereshchenko |
| collection | DOAJ |
| description | <p>A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally different mechanisms of action, is presented in patients with chronic heart failure (CHF) on the base of GISSI-HF and SHIFT trails results. It is essential to compaire an effect of these drugs on the morbidity and mortality in combined therapy of patients with CHF , because each additional drug may change in compliance to treatment, induces additional costs or may be a reason of new side effects. Additional (to standard therapy) effects of ivabradine and omega-3 polyunsaturated fatty acids are discussed.</p> |
| first_indexed | 2024-03-12T20:31:27Z |
| format | Article |
| id | doaj.art-938ed44d108446cfbf1f15d5ddd7ce70 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-03-12T20:31:27Z |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-938ed44d108446cfbf1f15d5ddd7ce702023-08-02T00:00:58ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-018221121910.1234/1819-6446-2012-2-211-219561THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASES. N. Tereshchenko0I. V. Zhirov1A. G. Kochetov2O. V. Uspenskaya3Научно-исследовательский институт кардиологии им А. Л. Мясникова, Российский кардиологический научно-производственный комплексНаучно-исследовательский институт кардиологии им А. Л. Мясникова, Российский кардиологический научно-производственный комплексНаучно-исследовательский институт цереброваскулярной патологии и инсульта, Российский национальный исследовательский медицинский университетНаучно-исследовательский институт кардиологии им А. Л. Мясникова, Российский кардиологический научно-производственный комплекс<p>A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally different mechanisms of action, is presented in patients with chronic heart failure (CHF) on the base of GISSI-HF and SHIFT trails results. It is essential to compaire an effect of these drugs on the morbidity and mortality in combined therapy of patients with CHF , because each additional drug may change in compliance to treatment, induces additional costs or may be a reason of new side effects. Additional (to standard therapy) effects of ivabradine and omega-3 polyunsaturated fatty acids are discussed.</p>http://www.rpcardio.ru/jour/article/view/561хроническая сердечная недостаточностьрандомизированное клиническое исследованиеивабрадиномега-3 полиненасыщенные жирные кислоты |
| spellingShingle | S. N. Tereshchenko I. V. Zhirov A. G. Kochetov O. V. Uspenskaya THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE Рациональная фармакотерапия в кардиологии хроническая сердечная недостаточность рандомизированное клиническое исследование ивабрадин омега-3 полиненасыщенные жирные кислоты |
| title | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE |
| title_full | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE |
| title_fullStr | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE |
| title_full_unstemmed | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE |
| title_short | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE |
| title_sort | new drug classes in the treatment of chronic heart failure and their evidence base |
| topic | хроническая сердечная недостаточность рандомизированное клиническое исследование ивабрадин омега-3 полиненасыщенные жирные кислоты |
| url | http://www.rpcardio.ru/jour/article/view/561 |
| work_keys_str_mv | AT sntereshchenko thenewdrugclassesinthetreatmentofchronicheartfailureandtheirevidencebase AT ivzhirov thenewdrugclassesinthetreatmentofchronicheartfailureandtheirevidencebase AT agkochetov thenewdrugclassesinthetreatmentofchronicheartfailureandtheirevidencebase AT ovuspenskaya thenewdrugclassesinthetreatmentofchronicheartfailureandtheirevidencebase AT sntereshchenko newdrugclassesinthetreatmentofchronicheartfailureandtheirevidencebase AT ivzhirov newdrugclassesinthetreatmentofchronicheartfailureandtheirevidencebase AT agkochetov newdrugclassesinthetreatmentofchronicheartfailureandtheirevidencebase AT ovuspenskaya newdrugclassesinthetreatmentofchronicheartfailureandtheirevidencebase |